United States · FDA National Drug Code directory
REZENOPY
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 83245-003_6585ecb7-d8c3-4f64-b485-8d0f0c61d376
- Product NDC
- 83245-003
- Form
- SPRAY
- Composition / generic term
- naloxone HCl
- Labeler
- Scienture LLC
- Marketing category
- NDA
- Marketing start / end (source format)
- 20260129
- Source listing expiry
- 20271231
Source-listed ingredients
- NALOXONE HYDROCHLORIDE — 10 mg/.11mL
These values do not establish equivalence or a dose recommendation.
Packages
- 2 BLISTER PACK in 1 CARTON (83245-003-01) / 1 VIAL, SINGLE-DOSE in 1 BLISTER PACK / .11 mL in 1 VIAL, SINGLE-DOSE · 83245-003-01
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →